Delivery Order SPE2DB22D2007-SPE2DB23FJ1YG
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $39,462.36, to provide Ondansetron ODT 4 mg Tablets. The contract has an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,685.40, is a firm-fixed-price delivery order with a completion date of February 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,245.38 delivery order is for Ondansetron ODT 4 mg tablets, with a completion date of May 2, 2023. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 MG Tablets, a pharmaceutical product, with a total ceiling value of $21,722.03. The contract has a completion date of May 15, 2023 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,915.23, is for the delivery of Ondansetron ODT 4 mg tablets. The award has an ultimate completion date of May 10, 2024, and is structured as a firm fixed-price delivery order contract. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $1,685.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 8 mg Ondansetron HCL tablets, with a completion date of May 3, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was awarded on May 2, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award, valued at $3,379.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,560,993,787 units of Ondansetron ODT 4 mg Tablet 30s, a pharmaceutical product. The contract has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,489.39, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ondansetron ODT 4 mg tablets. The award, valued at $7,649.00, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 5, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ondansetron ODT 4 mg tablets. The contract, valued at $1,927.30, is a firm-fixed price delivery order that runs through December 20, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ1YGDelivery Order
This federal contract award, valued at $22,448.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets to support military healthcare programs. It is a firm-fixed-price delivery order with an ultimate completion date of April 28, 2023. The contract was awarded through full and open competition, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within the Department of Defense (DoD) and Department of Veterans Affairs (VA) systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, to provide a comprehensive range of pharmaceutical products and medical supplies to support government healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 4/27/23 |